City

Houston (2)

Rochester (1)

Overall Status

Active, not recruiting (3)

Phase

phase 1/phase 2 (1)

phase 2 (1)

phase 3 (1)

Sponsor

M.D. Anderson Cancer Center (2)

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (3)

Intervention

rituximab (2)

clinical observation (1)

external beam radiation therapy (1)

orbital radiation (1)

quality-of-life assessment (1)

radiation therapy (1)

yttrium y-90 ibritumomab tiuxetan (1)

Study Documents

Intervention Type

radiation (3)

biological (2)

other (2)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (3)

ann arbor stage i grade 1 follicular lymphoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

Active, not recruiting

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
+22 more

External Beam Radiation Therapy
Orbital Radiation

Houston, Texas

M D Anderson Cancer Center

Dec 9, 2022

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting

Ann Arbor Stage I Grade 1 Follicular Lymphoma
+3 more

Clinical Observation
+2 more

Houston, Texas

M D Anderson Cancer Center

Dec 5, 2022

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting

Ann Arbor Stage I Grade 1 Follicular Lymphoma
+9 more

Quality-of-Life Assessment
+2 more

Rochester, Minnesota

Mayo Clinic in Rochester

Feb 3, 2022